Antiphospholipid antibodies and thrombosis: Assessment of the potential risk for thrombosis

Lupus

Volumn 5, Issue 2, 1996, Pages 163-166

  Salem, H H ^a  

^a BOX HILL HOSPITAL   (Australia)

Author keywords

Activated protein C resistance; Lupus anticoagulent; Protein C

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR 5; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIGEN ANTIBODY REACTION; BLOOD CLOTTING TIME; CONFERENCE PAPER; GENE MUTATION; HEMOSTASIS; HUMAN; LUPUS ERYTHEMATOSUS; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THROMBOSIS;

EID: 0029881610     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500216     Document Type: Conference Paper

References (24)

1. Triplett DA, Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78: 1-31.
2. 2 Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 4120-4124.
3. Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only but to a complex of lipid bound prothrombin. Thromb Haemost 1991, 66: 629-632.
4. Matsuda J et al. Anti-annexin antibody in the sera of patients with habitual fetal loss or pre-eclampsia. Thromb Res 1994; 75: 105-106.
5. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S. An explanation for their pathogenic mechanism. Blood 1993; 81: 2618-2625.
6. Sugi T, McIntyre JA. Auto-antibodies to phosphatidylethanolamine (PE) recognise a kinogen-PE complex. Blood 1995; 86: 3083-3089.
7. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430.
8. Ginsberg KS et al. Anticardiolipin antibodies and the risk for ischaemic stroke and venous thrombosis. Annals of Internal Medicine 1992; 117: 997-1002.
9. Taylor LM et al. Antiphospholipid antibodies in vascular surgery patients. Ann Surg 1994; 220: 544-551.
10. Morton KE et al. Coronary artery bypass graft failure - an autoimmune phenomenon? Lancet 1986; 2: 1353-1357.
11. Ginsberg JS et al. Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood 1993; 81: 2958-2963.
12. Khamashta MA et al. The management of thrombosis in the antiphospholipid antibody syndrome. New Eng J Med 1995; 332(15): 993-997.
13. Denheizer M et al. Is hyperhomocystinaemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-885.
14. Naworth PD, Handley DA, Esmon CT, Slern D. Interleukin I induces endothelial procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460.
15. Comp PC et al. Acquired protein S deficiency occurs in pregnancy, the nephrotic syndrome and systemic lupus erythematosus. Blood 1985; 66: 348.
16. Dahlback B. Inherited thrombophilia resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-614.
17. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352.
18. Griffin JH et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373.
19. Mitchell CA et al. A fatal thrombotic disorder associated with an acquired inhibitor of protein C. New Engl J Med 1987; 317: 1638-1642.
20. Odegaard B, Mann KG: Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 1987; 262: 11233.
21. Zoller B, Dahlback B: Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536.
22. Heeb MJ, Kojima Y, Greengard JS, Griffin JH. Activated protein C resistance molecular mechanisms based on studies using purified (GLN 506) Factor V. Blood 1995; 85: 3405-3411.
23. Hellgren M, Svenson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gyn 1995; 173: 210-213.
24. Ridker PM et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. New Engl J Med 1995; 332:912-917.